ENDODIABETO: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ENDODIABETO
Largest movements
- Receivables within one year +€30,908
up €30,908 (+19.5%), from €158,427 to €189,336
- Accrued charges and deferred income +€34,316
up €34,316 (+20.8%), from €164,750 to €199,066
- Profit (loss) carried forward -€5,044
down €5,044 (-111%), from -€4,546 to -€9,590
- Gross operating margin -€4,054
down €4,054 (-929%), from -€437 to -€4,491
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €170,073 | €200,122 | +€30,049 | +17.7% |
| Current assets | 29/58 | €170,073 | €200,122 | +€30,049 | +17.7% |
| Amounts receivable within one year | 40/41 | €158,427 | €189,336 | +€30,908 | +19.5% |
| Other amounts receivable | 41 | €158,427 | €189,336 | +€30,908 | +19.5% |
| Cash at bank and in hand | 54/58 | €11,646 | €10,786 | -€860 | -7.4% |
| Total equity and liabilities | 10/49 | €170,073 | €200,122 | +€30,049 | +17.7% |
| Equity | 10/15 | €454 | -€4,590 | -€5,044 | |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€4,546 | -€9,590 | -€5,044 | -111% |
| Amounts payable | 17/49 | €169,619 | €204,712 | +€35,093 | +20.7% |
| Amounts payable within one year | 42/48 | €4,869 | €5,646 | +€777 | +16.0% |
| Trade debts | 44 | €4,869 | €5,646 | +€777 | +16.0% |
| Suppliers | 440/4 | €4,869 | €5,646 | +€777 | +16.0% |
| Accrued charges and deferred income | 492/3 | €164,750 | €199,066 | +€34,316 | +20.8% |
| Other operating charges | 640/8 | €387 | €400 | +€12 | +3.2% |
| Gross operating margin | 9900 | -€437 | -€4,491 | -€4,054 | -929% |
| Operating profit (loss) | 9901 | -€824 | -€4,891 | -€4,067 | -494% |
| Financial charges | 65/66B | €140 | €154 | +€13 | +9.4% |
| Recurring financial charges | 65 | €140 | €154 | +€13 | +9.4% |
| Profit (loss) for the period before taxes | 9903 | -€964 | -€5,044 | -€4,080 | -423% |
| Profit (loss) for the period | 9904 | -€964 | -€5,044 | -€4,080 | -423% |
| Profit (loss) for the period to be appropriated | 9905 | -€964 | -€5,044 | -€4,080 | -423% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.